Status:
UNKNOWN
Hypotension Prediction With HPI Algorithm During Decessed-donor Kidney Transplant (HPI2022)
Lead Sponsor:
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions:
Hypotension During Surgery
Kidney Transplant; Complications
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
HPI monitoring and the adoption of therapeutic interventions before hypotension occurs should be ensure a shorter time of intra-operative hypotension (MAP \< 65 mmHg) during deceased-donor kidney tran...
Eligibility Criteria
Inclusion
- First single or double kidney transplant from a cadaveric donor;
- ASA Class III-IV;
- Signature of informed consent.
Exclusion
- Patient with atrial fibrillation rhythm or high frequency tachyarrhythmias;
- Severe valvulopathies;
- Combined single/double kidney-liver-transplant;
- Patients in whom the need for monitoring would still be expected advanced, invasive or minimally invasive hemodynamic, regardless of the allocation to the study group;
- Inclusion in another study.
Key Trial Info
Start Date :
November 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2024
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT05394896
Start Date
November 1 2022
End Date
January 31 2024
Last Update
January 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy, 40100